• Early breast cancer: Prognostic markers and updates of TAILORx and KATHERINE data

    New data for prognostic markers in early breast cancer as well as further analyses of the Phase 3 studies TAILORx and KATHERINE were presented at the ESMO Congress 2019 in Barcelona.

  • Measuring blood pressure with a “selfie” video

    Could smartphones be used to measure blood pressure? Canadian and Chinese researchers are suggesting that the smartphone camera could be used to make it easier to check blood pressure.

  • Melanoma: Good results with neoadjuvant and adjuvant therapy

    A vast array of study results on melanoma were presented by Piotr Rutkowski, from the Maria Skłodowska-Curie Institute of Oncology, Warsaw, Poland, during a highlight session at the ESMO Congress 2019.

  • Sarcoma: New data on ripretinib, regorafenib, sunitinib and nivolumab

    Sarcomas are relatively rare tumors that can occur on the soft tissue or bone. New study data on their treatment was presented by Javier Martin-Broto, Virgen del Rocio University Hospital, Seville, Spain.

  • NSCLC: Nivolumab plus low-dose ipilimumab used for first line therapy

    Treatment with a combined immunotherapy of nivolumab plus low-dose ipilimumab prolonged overall survival compared to chemotherapy in previously untreated patients with advanced NSCLC regardless of PD-L1 expression of the tumor.

  • NSCLC: Osimertinib as first-line therapy improves overall survival

    First-line therapy with osimertinib significantly prolongs overall survival of patients with non-small-cell lung carcinoma (NSCLC) compared to older tyrosine kinase inhibitors. This was shown by the evaluation of survival data from the FLAURA study

  • PARP inhibitors: New standard in first-line therapy of ovarian cancer?

    Three new studies with the PARP inhibitors niraparib, olaparib and veliparib showed a significant reduction in the risk of progression in first-line therapy of women with ovarian cancer.

  • Checkpoint inhibition in head and neck tumors

    The results of a 2018 comparative study were as good for inhibitors as those achieved with aggressive chemotherapy. The use of these drugs is currently being tested in the so-called ADRISK study at 13 ENT clinics in Germany.

  • Antibodies fighting HPV16 can indicate early tumor risk

    Antibodies against the human papillomavirus (HPV) 16 can be detected up to 40 years before the diagnosis of a head and neck tumor. People with HPV16 antibodies also have a much higher risk of oropharyngeal tumors.

  • An artificial heart from the printer

    Researchers at Carnegie Mellon University, USA, have developed a technique to produce biological tissue from collagens using 3D printing. The new method is an important step on the way to printing a first functioning human heart.

  • Researchers uncover new mechanism for the development of allergic immune reactions

    A recent research project at the Medical University of Innsbruck, Austria found a new mechanism for certain allergic immune reactions. The team investigated lipocalins and identified FPR 3 as the central player of this allergic reaction.

  • Genetic fitness becomes measurable

    Scientists from the Fraunhofer Society in Germany have developed a method to check the condition of human genetic material, to detect the changes at the chemical and molecular level that come with aging. This may open the door to new drugs and to track health or diseases.

  • Unusual HB virus in mice

    A recent study by an international team of researchers opens up new possibilities for research into the pathogenesis of hepatitis B viruses. The basis for this is a newly discovered, unusual HB virus in mice.

  • Farm air can reduce the risk of asthma

    Bronchial asthma is one of the most common chronic childhood diseases. While the prevalence is high in urban areas with high hygiene standards, children who grow up on farms or in rural areas are often protected from allergies and asthma.

  • Dizziness caused by perception disorders

    An experiment at the Munich Technical University has for the first time clarified possible causes of functional dizziness. These patients have problems with sensorimotor processing in the brain that are similar to those of people with organic causes for dizziness.

  • Inflammatory reaction caused by the human body's own protein

    Scientists from Jena, Germany, have identified a human protein that triggers autoinflammatory reactions. If the inflammation is part of the healing process, it worsens the situation in patients with chronic vasculitis, for example.

  • Possible link between viral infections in children and multiple sclerosis

    A potential link between neurological viral infections and the risk of developing autoimmune diseases in adulthood discovered.

  • Researchers study the brains of people with great general knowledge

    The brains of people with a high level of general knowledge are particularly efficiently networked. This was demonstrated by neuroscientists at the German Ruhr University Bochum and Humboldt-University of Berlin using magnetic resonance imaging.

  • Most antibiotic-resistant bacteria are distributed across health centres

    Genetic analyses make Europe-wide distribution paths of pathogens visible. Researchers recognized that hospitals are decisive resistant bacteria multipliers.

  • Improving the quality of life in cities

    A research team showed that green spaces directly improve the wellbeing of city dwellers in their everyday lives. Also, they investigated brain function to identify the people who benefit most from them.

  • 69 |
  • 70 |
  • 71 |
  • 72 |
  • 73 |
  • 74 |
  • 75 |
  • 76 |
  • 77 |
  • 78 |
  • 79 |